Virtual care company Recuro Health raises $47 million
Recuro Santé integrated care virtual platform announced the closing of a $47 million Series B funding round.
ARCH Venture Partners, Flippen Group, GPG Ventures, 4D Capital and other investors participated in the lifting.
WHAT THEYRE DOING
Recuro Health’s Digital Medical Home offering allows patients to virtually access health services, including behavioral health care, virtual primary and urgent care, genomic testing and laboratory testing at home.
The company is also working with employers to create customizable digital health offerings for their employees, and with plans and healthcare providers to help connect their members and patients to the right care teams.
Recuro will use the funds to advance and scale its digital home medical care model, which includes virtual primary care and behavioral health offerings.
“The continued support of our investors is a clear sign of their confidence in our mission,” Michael Gorton, CEO and Founder of Recuro Health, said in a statement. “We have an amazing team at Recuro dedicated to changing healthcare to be more proactive and personal, resulting in better outcomes, better patient engagement and lower costs. In this next phase of growth and As our business expands, we are committed to building on the success of our Digital Medical Home and continuing to advance the next generation of digital healthcare services.”
In 2021, the company collected $15 million in Series A funding.
That same year, the company purchased MyLifeIQan epigenetics platform, and SupDocan AI-based virtual health platform.
Last year, Recuro acquired WellViaa virtual healthcare provider that connects patients with physicians and behavioral health specialists.
He also announced his acquisition of digital health company Competitive Healthwhich offers employers products to help reduce costs, maximize employer return on investment and promote engagement.
Recuro Health recently announced that it join Microsoft as a Featured Partner To HIMSS23 Global Conference next week.
Glen Tullman will offer more details during the HIMSS23 session “Views from the Top: Existential Crisis or Inflection Point Opportunity? An Industry Maverick’s Perspective.” It is scheduled for Tuesday, April 18 from 3-4 p.m. CT at the South Building, Level 1, Room S100 B.